Nebula Research & Development LLC Xencor Inc Transaction History

Nebula Research & Development LLC

  • $836 Billion
  • Q3 2024

A detailed history of Nebula Research & Development LLC transactions in Xencor Inc stock. As of the latest transaction made, Nebula Research & Development LLC holds 20,383 shares of XNCR stock, worth $531,180. This represents 0.05% of its overall portfolio holdings.

Number of Shares
20,383
Holding current value
$531,180
% of portfolio
0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$15.7 - $21.65 $320,013 - $441,291
20,383 New
20,383 $410 Million
Q4 2023

Feb 14, 2024
BUY
$16.53 - $21.42 $449,070 - $581,917
27,167 New
27,167 $577 Million

Others Institutions Holding XNCR

# of Institutions
216
Shares Held
71.8M
Call Options Held
2.5K
Put Options Held
7.9K
View Full List

About Xencor Inc

XNCR Quotes by TradingView
  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.56B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Nebula Research & Development LLC Portfolio

Follow Nebula Research & Development LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nebula Research & Development LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email